NCBiotech News

When pharmaceutical companies win regulatory approval for a drug to be sold – a long and expensive journey that requires successful phase 1, 2 and 3 clinical trials – their work is far from over.

Michael Kelly, chief financial officer of Piedmont Pharmaceuticals, has been named chair of the newly seated 24-member Advisory Committee for Biotechnology in the Piedmont Triad and Daniel Erb, PT, Ph.D., dean of the High Point University School of Health Sciences, will serve as vice chair.

Duke University has received a $15 million grant from The Marcus Foundation for research focused on umbilical cord blood cells to treat autism, stroke and other neurological disorders.  

Michael Kelly, COO and CFO at Greensboro-based Piedmont Pharmaceuticals, has been named vice chair of the North Carolina Biotechnology Center’s Advisory Committee for Biotechnology in the Piedmont Triad.

Norris Tolson, President and CEO of the North Carolina Biotechnology Center, today announced that he will be stepping down, effective June 30. The NCBiotech Board of Directors will begin a search for Tolson’s successor.

I love the January NCBiotech Jobs Network events! Everyone comes back from the holidays recharged and revving their “search engines” to reinvigorate their job search. So it’s no surprise that we had a packed house January 27 for our first NCBiotech Jobs Network of 2014. And since it’s a new year, it’s only fitting for the NCBiotech Jobs Network to revisit a basic 101-level course: Intro to … well, intros. Because for most of us, our college degrees didn’t include job-search training.

Chapel Hill development-stage biopharmaceutical company NeuroGate Therapeutics, a UNC spinout, has been awarded a $25,000 grant from the Epilepsy Foundation to help the company develop its unique treatment for the debilitating condition.

In his career spanning six decades, Norris Tolson has earned some distinguished titles. Executive. Representative. Secretary. President and CEO.

Tuesday night, the North Carolina Biotechnology Center president and CEO added one more: North Carolina Business Hall of Fame Laureate.

Medicago and Mitsubishi this morning announced that Japan-based Mitsubishi Tanabe Pharma will acquire the Canadian vaccine company for $357 million.
 

The Sequenom Center for Molecular Medicine has opened its Morrisville laboratory for processing of the company’s MaterniT21 PLUS non-invasive prenatal blood test to detect Down syndrome from a woman’s blood sample as early as 10 weeks of pregnancy.

Chapel Hill biotech firm Heat Biologics filed for a $20 million IPO last week, as the company continues to secure funding for ongoing clinical trials of its unique platform for treating cancer and infectious diseases.

If your New Year’s resolution is to get out of a low-paying, dead-end job and make a move into a good-paying, fulfilling career in the biopharmaceutical industry, you need to attend the free BPD Spotlight on Education event this Thursday, January 17, from 12:30 to 4 p.m., at the North Carolina Biotechnology Center.

Olav Rueppell, Ph.D., says his research at the University of North Carolina Greensboro clearly illustrates how relatively small but timely grant funding from the North Carolina Biotechnology Center can have a big impact.

Half of U.S. honeybee colonies have been wiped out in the last decade, which worries many in agriculture since a third of our food relies on honeybee fertilization.

The North Carolina Biotechnology Center awarded 47 loans and grants totaling $3.6 million to universities, bioscience companies and other entities in the fourth quarter of its 2016-2017 fiscal year ending June 30.